Market Cap 431.21M
Revenue (ttm) 35.95M
Net Income (ttm) -104.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -292.04%
Debt to Equity Ratio 0.00
Volume 2,849,600
Avg Vol 2,970,970
Day's Range N/A - N/A
Shares Out 110.57M
Stochastic %K 40%
Beta 2.92
Analysts Strong Sell
Price Target $12.29

Company Profile

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally bioavailable monodac targeting IKZF1 and IKZF3, or IKZF1/3 to address a need across multiple lines of therapy in multiple myeloma, which has competed its phase 1. The company is also developing oncology product candidate, CFT8919, an orally bioavailable, allosteric, mutant-selective bidac degrader of epi...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 231 0700
Address:
490 Arsenal Way, Suite120, Watertown, United States
JuggernautRaider
JuggernautRaider Jun. 14 at 8:09 AM
Been in $SLS since it was $1.50. $TNXP $IMRX $CCCC some of my other favorites. Hit me again - right @Night_Owl_Biotech ? 😉 ♣️ 🚀
1 · Reply
JuggernautRaider
JuggernautRaider Jun. 14 at 7:19 AM
$TNXP screw Symphony. Here’s a simplified quarterly summary of my base case for sales. If the LLC launches soon, it will be for Healthcare and Inestment Educational Purposes. This distinction is important: while I am an expert in some fields… I am not an advisor. Do your own damn due diligence. Tonix is not my only investment in biopharma but it is one of my favorites… i want to share more on $NUVB $IMRXAND $CCCC (and also some awful biopharmas to avoid at all costs long! ;) The Bonesaw of Biotech’s Net Sales Forecast - Juneteenth Edition 2026 10th pecentile ~ Base ~ 90th Percentile Q1’26 $3.4M (actual) Q2’26 $6.0 ~ 7.8 ~ 10.0M Q3’26 $8.5 ~ 11.1 ~ 18.0M Q4’26 $11.0 ~ 15.4 ~ 28.0M Q1’27 $14.0~ 19.5 ~ 40.0M Q2’27 $18.0 ~ 25.8 ~ 55.0M Q3’27 $24.0 ~ 34.5 ~ 75.0M Q4’27 $30.0 ~ 44.0 ~ 95.0M ~~~Base Net Sales Projection for 2026 Jan-Mar $3.4M (actual) Apr $1.8M May $2.9M Jun $3.0M Jul $3.3M Aug $3.7M Sep $4.1M Oct $4.6M Nov $5.1M Dec $5.7M
2 · Reply
2tacos_plis
2tacos_plis Jun. 12 at 4:36 PM
$CCCC Buying conviction still holding stronger than sells. Could see this test 52 week highs. Show us!
0 · Reply
zawojak
zawojak Jun. 12 at 4:06 PM
$CCCC nice volume but sell off Friday. If it holds 4$ today I am happy.
0 · Reply
Andysss
Andysss Jun. 12 at 2:46 PM
$CCCC like the webinar next week. They r setting this up perfectly
0 · Reply
zawojak
zawojak Jun. 12 at 11:54 AM
$CCCC waiting for that one long candle bringing it to $4.70 level.
0 · Reply
zawojak
zawojak Jun. 12 at 9:58 AM
$CCCC its calm like before BO news 😁
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 12 at 9:43 AM
$ALLR $CCCC $IMRX $GMAB three of these are incredible long holds; the other is a large cap with potential, albeit an odd leadership structure 🤔
0 · Reply
zawojak
zawojak Jun. 12 at 8:18 AM
$CCCC Price target increased by 15% to US$13.33 Up from US$11.57, the current price target is an average from 6 analysts. New target price is 245% above last closing price of US$3.87. Stock is up 139% over the past year. The company is forecast to post a net loss per share of US$0.93 next year compared to a net loss per share of US$1.27 last year.
0 · Reply
zawojak
zawojak Jun. 12 at 8:16 AM
$CCCC never seen it so static
0 · Reply
Latest News on CCCC
C4 Therapeutics jumps after Bristol Myers myeloma data

2026-05-29T15:51:38.000Z - 16 days ago

C4 Therapeutics jumps after Bristol Myers myeloma data

BMY


C4 Therapeutics to Participate in Upcoming Conferences

May 20, 2026, 7:00 AM EDT - 25 days ago

C4 Therapeutics to Participate in Upcoming Conferences


C4 Therapeutics reports Q1 EPS (20c), consensus (26c)

2026-05-12T12:40:38.000Z - 4 weeks ago

C4 Therapeutics reports Q1 EPS (20c), consensus (26c)


C4 Therapeutics Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 4 weeks ago

C4 Therapeutics Quarterly report: Q1 2026


C4 Therapeutics Earnings release: Q1 2026

May 12, 2026, 7:00 AM EDT - 4 weeks ago

C4 Therapeutics Earnings release: Q1 2026


C4 Therapeutics Slides: Investor presentation

May 12, 2026, 7:00 AM EDT - 4 weeks ago

C4 Therapeutics Slides: Investor presentation


C4 Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 6 weeks ago

C4 Therapeutics Proxy statement: Proxy filing


C4 Therapeutics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 6 weeks ago

C4 Therapeutics Proxy statement: Proxy filing


C4 Therapeutics expands long-term partnership with Roche

2026-04-09T11:07:07.000Z - 2 months ago

C4 Therapeutics expands long-term partnership with Roche


C4 Therapeutics Slides: Corporate presentation

Apr 8, 2026, 7:00 AM EDT - 2 months ago

C4 Therapeutics Slides: Corporate presentation


C4 Therapeutics doses first patient in cemsidomide trial

2026-03-25T11:25:28.000Z - 2 months ago

C4 Therapeutics doses first patient in cemsidomide trial


C4 Therapeutics Slides: Corporate presentation

Mar 2, 2026, 6:00 AM EST - 3 months ago

C4 Therapeutics Slides: Corporate presentation


C4 Therapeutics price target raised to $7 from $5 at Barclays

2026-02-27T10:25:32.000Z - 3 months ago

C4 Therapeutics price target raised to $7 from $5 at Barclays


C4 Therapeutics reports Q4 EPS (18c), consensus (34c)

2026-02-26T12:08:51.000Z - 3 months ago

C4 Therapeutics reports Q4 EPS (18c), consensus (34c)


C4 Therapeutics Annual report: Q4 2025

Feb 26, 2026, 7:00 AM EST - 3 months ago

C4 Therapeutics Annual report: Q4 2025


C4 Therapeutics Earnings release: Q4 2025

Feb 26, 2026, 7:00 AM EST - 3 months ago

C4 Therapeutics Earnings release: Q4 2025


C4 Therapeutics Slides: Corporate presentation

Feb 25, 2026, 7:00 AM EST - 3 months ago

C4 Therapeutics Slides: Corporate presentation


C4 Therapeutics to Participate in Upcoming March Conferences

Feb 23, 2026, 7:10 AM EST - 3 months ago

C4 Therapeutics to Participate in Upcoming March Conferences


C4 Therapeutics outlines milestones through 2028

2026-01-14T12:05:59.000Z - 5 months ago

C4 Therapeutics outlines milestones through 2028


C4 Therapeutics price target lowered to $5 from $10 at Barclays

2025-12-17T10:55:09.000Z - 6 months ago

C4 Therapeutics price target lowered to $5 from $10 at Barclays


C4 Therapeutics initiated with a Buy at TD Cowen

2025-12-02T10:40:12.000Z - 6 months ago

C4 Therapeutics initiated with a Buy at TD Cowen


C4 Therapeutics files $400M mixed securities shelf

2025-11-21T21:10:22.000Z - 7 months ago

C4 Therapeutics files $400M mixed securities shelf


C4 Therapeutics Registration statement: Registration Filing

Nov 21, 2025, 7:00 AM EST - 7 months ago

C4 Therapeutics Registration statement: Registration Filing


C4 Therapeutics reports Q3 EPS (44c), consensus (38c)

2025-11-06T12:24:51.000Z - 7 months ago

C4 Therapeutics reports Q3 EPS (44c), consensus (38c)


C4 Therapeutics sees cash runway to the end of 2028

2025-11-06T12:24:45.000Z - 7 months ago

C4 Therapeutics sees cash runway to the end of 2028


C4 Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 7 months ago

C4 Therapeutics Earnings release: Q3 2025


C4 Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 7 months ago

C4 Therapeutics Quarterly report: Q3 2025


C4 Therapeutics Slides: Corporate Presentation

Nov 5, 2025, 6:00 PM EST - 7 months ago

C4 Therapeutics Slides: Corporate Presentation


C4 Therapeutics Slides: Corporate Presentation

Nov 4, 2025, 6:00 PM EST - 7 months ago

C4 Therapeutics Slides: Corporate Presentation


C4 Therapeutics prices $125M underwritten offering

2025-10-16T11:20:33.000Z - 8 months ago

C4 Therapeutics prices $125M underwritten offering


C4 Therapeutics price target raised to $10 from $8 at Barclays

2025-09-22T11:15:14.000Z - 9 months ago

C4 Therapeutics price target raised to $10 from $8 at Barclays


C4 Therapeutics presents data from Phase 1 trial of cemsidomide

2025-09-21T14:55:14.000Z - 9 months ago

C4 Therapeutics presents data from Phase 1 trial of cemsidomide


C4 Therapeutics Transcript: Status Update

Sep 20, 2025, 3:00 PM EDT - 9 months ago

C4 Therapeutics Transcript: Status Update


C4 Therapeutics Slides: Status Update

Sep 20, 2025, 3:00 PM EDT - 9 months ago

C4 Therapeutics Slides: Status Update


C4 Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 11 months ago

C4 Therapeutics Earnings release: Q2 2025


C4 Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 7:00 AM EDT - 11 months ago

C4 Therapeutics Quarterly report: Q2 2025


C4 Therapeutics Earnings release: Q1 2025

May 7, 2025, 7:00 AM EDT - 1 year ago

C4 Therapeutics Earnings release: Q1 2025


C4 Therapeutics Quarterly report: Q1 2025

May 7, 2025, 7:00 AM EDT - 1 year ago

C4 Therapeutics Quarterly report: Q1 2025


C4 Therapeutics Slides: Corporate Presentation

May 7, 2025, 7:00 AM EDT - 1 year ago

C4 Therapeutics Slides: Corporate Presentation


C4 Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

C4 Therapeutics Proxy statement: Proxy Filing


C4 Therapeutics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

C4 Therapeutics Proxy statement: Proxy Filing


C4 Therapeutics Proxy statement: Proxy Filing

Apr 16, 2025, 8:00 AM EDT - 1 year ago

C4 Therapeutics Proxy statement: Proxy Filing


C4 Therapeutics Earnings release: Q4 2024

Feb 27, 2025, 7:00 AM EST - 1 year ago

C4 Therapeutics Earnings release: Q4 2024


C4 Therapeutics Annual report: Q4 2024

Feb 27, 2025, 7:00 AM EST - 1 year ago

C4 Therapeutics Annual report: Q4 2024


C4 Therapeutics Slides: Corporate Presentation

Feb 26, 2025, 7:00 AM EST - 1 year ago

C4 Therapeutics Slides: Corporate Presentation


C4 Therapeutics Slides: FY 2025

Jan 15, 2025, 5:15 PM EST - 1 year ago

C4 Therapeutics Slides: FY 2025


C4 Therapeutics Transcript: Status Update

Dec 8, 2024, 5:00 PM EST - 1 year ago

C4 Therapeutics Transcript: Status Update


C4 Therapeutics Slides: Status Update

Dec 8, 2024, 5:00 PM EST - 1 year ago

C4 Therapeutics Slides: Status Update


C4 Therapeutics Registration statement: Registration Filing

Oct 31, 2024, 8:00 AM EDT - 1 year ago

C4 Therapeutics Registration statement: Registration Filing


C4 Therapeutics Registration statement: Registration Filing

Oct 31, 2024, 8:00 AM EDT - 1 year ago

C4 Therapeutics Registration statement: Registration Filing


C4 Therapeutics Quarterly report: Q3 2024

Oct 31, 2024, 7:00 AM EDT - 1 year ago

C4 Therapeutics Quarterly report: Q3 2024


C4 Therapeutics Earnings release: Q3 2024

Oct 31, 2024, 7:00 AM EDT - 1 year ago

C4 Therapeutics Earnings release: Q3 2024


C4 Therapeutics Transcript: Study Update

Sep 13, 2024, 12:00 PM EDT - 1 year ago

C4 Therapeutics Transcript: Study Update


C4 Therapeutics Press release: Study Update

Sep 13, 2024, 12:00 PM EDT - 1 year ago

C4 Therapeutics Press release: Study Update


C4 Therapeutics Slides: Study Update

Sep 13, 2024, 12:00 PM EDT - 1 year ago

C4 Therapeutics Slides: Study Update


C4 Therapeutics Quarterly report: Q2 2024

Aug 1, 2024, 7:04 AM EDT - 2 years ago

C4 Therapeutics Quarterly report: Q2 2024


C4 Therapeutics Earnings release: Q2 2024

Aug 1, 2024, 7:04 AM EDT - 2 years ago

C4 Therapeutics Earnings release: Q2 2024


C4 Therapeutics Quarterly report: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

C4 Therapeutics Quarterly report: Q1 2024


C4 Therapeutics Earnings release: Q1 2024

May 8, 2024, 7:00 AM EDT - 2 years ago

C4 Therapeutics Earnings release: Q1 2024


C4 Therapeutics Slides: Corporate Presentation

May 7, 2024, 7:00 AM EDT - 2 years ago

C4 Therapeutics Slides: Corporate Presentation


C4 Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

C4 Therapeutics Proxy statement: Proxy Filing


C4 Therapeutics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

C4 Therapeutics Proxy statement: Proxy Filing


C4 Therapeutics Earnings release: Q4 2023

Feb 22, 2024, 7:00 AM EST - 2 years ago

C4 Therapeutics Earnings release: Q4 2023


C4 Therapeutics Annual report: Q4 2023

Feb 22, 2024, 7:00 AM EST - 2 years ago

C4 Therapeutics Annual report: Q4 2023


C4 Therapeutics Slides: FY 2024

Jan 11, 2024, 12:00 PM EST - 2 years ago

C4 Therapeutics Slides: FY 2024


C4 Therapeutics Slides: Corporate Presentation

Jan 11, 2024, 7:00 AM EST - 2 years ago

C4 Therapeutics Slides: Corporate Presentation


C4 Therapeutics Transcript: Study Update

Dec 12, 2023, 4:30 PM EST - 2 years ago

C4 Therapeutics Transcript: Study Update


C4 Therapeutics Quarterly report: Q3 2023

Nov 1, 2023, 8:00 AM EDT - 2 years ago

C4 Therapeutics Quarterly report: Q3 2023


C4 Therapeutics Earnings release: Q3 2023

Nov 1, 2023, 8:00 AM EDT - 2 years ago

C4 Therapeutics Earnings release: Q3 2023


JuggernautRaider
JuggernautRaider Jun. 14 at 8:09 AM
Been in $SLS since it was $1.50. $TNXP $IMRX $CCCC some of my other favorites. Hit me again - right @Night_Owl_Biotech ? 😉 ♣️ 🚀
1 · Reply
JuggernautRaider
JuggernautRaider Jun. 14 at 7:19 AM
$TNXP screw Symphony. Here’s a simplified quarterly summary of my base case for sales. If the LLC launches soon, it will be for Healthcare and Inestment Educational Purposes. This distinction is important: while I am an expert in some fields… I am not an advisor. Do your own damn due diligence. Tonix is not my only investment in biopharma but it is one of my favorites… i want to share more on $NUVB $IMRXAND $CCCC (and also some awful biopharmas to avoid at all costs long! ;) The Bonesaw of Biotech’s Net Sales Forecast - Juneteenth Edition 2026 10th pecentile ~ Base ~ 90th Percentile Q1’26 $3.4M (actual) Q2’26 $6.0 ~ 7.8 ~ 10.0M Q3’26 $8.5 ~ 11.1 ~ 18.0M Q4’26 $11.0 ~ 15.4 ~ 28.0M Q1’27 $14.0~ 19.5 ~ 40.0M Q2’27 $18.0 ~ 25.8 ~ 55.0M Q3’27 $24.0 ~ 34.5 ~ 75.0M Q4’27 $30.0 ~ 44.0 ~ 95.0M ~~~Base Net Sales Projection for 2026 Jan-Mar $3.4M (actual) Apr $1.8M May $2.9M Jun $3.0M Jul $3.3M Aug $3.7M Sep $4.1M Oct $4.6M Nov $5.1M Dec $5.7M
2 · Reply
2tacos_plis
2tacos_plis Jun. 12 at 4:36 PM
$CCCC Buying conviction still holding stronger than sells. Could see this test 52 week highs. Show us!
0 · Reply
zawojak
zawojak Jun. 12 at 4:06 PM
$CCCC nice volume but sell off Friday. If it holds 4$ today I am happy.
0 · Reply
Andysss
Andysss Jun. 12 at 2:46 PM
$CCCC like the webinar next week. They r setting this up perfectly
0 · Reply
zawojak
zawojak Jun. 12 at 11:54 AM
$CCCC waiting for that one long candle bringing it to $4.70 level.
0 · Reply
zawojak
zawojak Jun. 12 at 9:58 AM
$CCCC its calm like before BO news 😁
0 · Reply
JuggernautRaider
JuggernautRaider Jun. 12 at 9:43 AM
$ALLR $CCCC $IMRX $GMAB three of these are incredible long holds; the other is a large cap with potential, albeit an odd leadership structure 🤔
0 · Reply
zawojak
zawojak Jun. 12 at 8:18 AM
$CCCC Price target increased by 15% to US$13.33 Up from US$11.57, the current price target is an average from 6 analysts. New target price is 245% above last closing price of US$3.87. Stock is up 139% over the past year. The company is forecast to post a net loss per share of US$0.93 next year compared to a net loss per share of US$1.27 last year.
0 · Reply
zawojak
zawojak Jun. 12 at 8:16 AM
$CCCC never seen it so static
0 · Reply
Bromberger
Bromberger Jun. 11 at 7:47 PM
$CCCC Just a small stop on the road to $7+.
0 · Reply
Andysss
Andysss Jun. 11 at 2:49 PM
$CCCC only big pharma gaining today. Rotation in to safer haven
1 · Reply
zawojak
zawojak Jun. 11 at 1:35 PM
$CCCC nothing burger news but rather positive
2 · Reply
demo1one
demo1one Jun. 11 at 1:24 PM
$PPBT Dear bagholders, Its not too late to full port $CCCC and make it all back. Trust
0 · Reply
open_outcry
open_outcry Jun. 11 at 12:21 PM
$CCCC https://ir.c4therapeutics.com/news-releases/news-release-details/c4-therapeutics-presents-phase-1-data-european-hematology
0 · Reply
Andysss
Andysss Jun. 11 at 11:34 AM
$CCCC someone must have seen…53% ORR. 75% post-BCMA. 7 prior lines. Still holding up.
1 · Reply
focafoca99
focafoca99 Jun. 11 at 11:33 AM
$CCCC communicated a Phase 1 trial poster and press release on cemsidomide for relapsed/refractory multiple myeloma.
1 · Reply
2tacos_plis
2tacos_plis Jun. 11 at 6:50 AM
$CCCC Not convinced this hasn’t stopped dropping. No bottom pivot found just yet. Sells still have more conviction than buys. I’ll jump back into the cool-aid once the sweating stops.
0 · Reply
zawojak
zawojak Jun. 11 at 6:28 AM
$CCCC holding well considering market conditions past 3 days.
0 · Reply
open_outcry
open_outcry Jun. 10 at 8:08 PM
$CCCC nice close. i can be patient here -- just grateful for a little flash of green in my sea of red
0 · Reply
TheUnmaker
TheUnmaker Jun. 10 at 6:13 PM
$TNXP is setting up for a moon shot to $15+ soon.. big coil forming on the chart. Don't be chasing! $QSI $SLS $CCCC $GALT
0 · Reply
TheUnmaker
TheUnmaker Jun. 10 at 5:49 PM
$TNXP Someone be loading! $CCCC $QSI $SLS $PFE
2 · Reply